Thursday, May 23, 2019
Home »
» Medical News Today: Depression: Esketamine trial leaves 'more questions than answers'
Medical News Today: Depression: Esketamine trial leaves 'more questions than answers'
A clinical trial for intranasal esketamine found it effective and safe for severe depression, leading to an FDA approval. But is this the end of the road?
Related Posts:
What I Found While Traveling Alone on the Holidays … Read More
2019 Charity Gift Guide: Do-Good Gifts for Everyone on Your List … Read More
The Ultimate Healthy Snack Guide for People Who Love to Eat … Read More
Weight loss surgery for children and teens struggling with obesityRight now, one in 12 children and adolescents in the US are severely obese. If that isn’t startling enough, consider this: among 12-to-15-year-olds, that number jumps to one in 10 — and among 16-to-19-year-olds, it is one in … Read More
5 Ways Food Pros Prioritize Well-Being Over Wellness Trends … Read More
0 comments:
Post a Comment